Cardiac fibroblasts regulate the development of heart failure via Htra3-TGF-β-IGFBP7 axis

心脏成纤维细胞通过Htra3-TGF-β-IGFBP7轴调控心力衰竭的发生发展。

阅读:2
作者:Toshiyuki Ko # ,Seitaro Nomura # ,Shintaro Yamada # ,Kanna Fujita ,Takanori Fujita ,Masahiro Satoh ,Chio Oka ,Manami Katoh ,Masamichi Ito ,Mikako Katagiri ,Tatsuro Sassa ,Bo Zhang ,Satoshi Hatsuse ,Takanobu Yamada ,Mutsuo Harada ,Haruhiro Toko ,Eisuke Amiya ,Masaru Hatano ,Osamu Kinoshita ,Kan Nawata ,Hiroyuki Abe ,Tetsuo Ushiku ,Minoru Ono ,Masashi Ikeuchi ,Hiroyuki Morita ,Hiroyuki Aburatani ,Issei Komuro

Abstract

Tissue fibrosis and organ dysfunction are hallmarks of age-related diseases including heart failure, but it remains elusive whether there is a common pathway to induce both events. Through single-cell RNA-seq, spatial transcriptomics, and genetic perturbation, we elucidate that high-temperature requirement A serine peptidase 3 (Htra3) is a critical regulator of cardiac fibrosis and heart failure by maintaining the identity of quiescent cardiac fibroblasts through degrading transforming growth factor-β (TGF-β). Pressure overload downregulates expression of Htra3 in cardiac fibroblasts and activated TGF-β signaling, which induces not only cardiac fibrosis but also heart failure through DNA damage accumulation and secretory phenotype induction in failing cardiomyocytes. Overexpression of Htra3 in the heart inhibits TGF-β signaling and ameliorates cardiac dysfunction after pressure overload. Htra3-regulated induction of spatio-temporal cardiac fibrosis and cardiomyocyte secretory phenotype are observed specifically in infarct regions after myocardial infarction. Integrative analyses of single-cardiomyocyte transcriptome and plasma proteome in human reveal that IGFBP7, which is a cytokine downstream of TGF-β and secreted from failing cardiomyocytes, is the most predictable marker of advanced heart failure. These findings highlight the roles of cardiac fibroblasts in regulating cardiomyocyte homeostasis and cardiac fibrosis through the Htra3-TGF-β-IGFBP7 pathway, which would be a therapeutic target for heart failure.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。